Topics:
Radiation Oncology • Genitourinary Cancers
How do you incorporate the recent proposed guidelines for using a prostate cancer "Grade Grouping" system (i.e. scores 1-5) into your clinical practice?
Recently, Epstein et al proposed using a Grade Group system of Groups 1 (GS < 6), 2 (GS 3+4=7), 3 (GS 4+3=7), 4 (GS 4+4=8), and 5 (GS 9-10). They showed that the grade grouping provides accurate predicition of prostate cancer outcomes and better conveys the good prognosis of a lower score which may help reduce overtreatment. How do you plan to incorporate this into your clinical practice? Do you find it helps or confuses patients who are familiar with the Gleason scoring system?
Answer from: Radiation Oncologist at Academic Institution
As theMedNet is a less formal venue for discourse I will do away with any pretense and answer the question honestly. I have no idea how I or anyone should incorporate this new system into practice. Although validated, the new system has not been used in randomized trials and one musn’t be over...
Sign in or Register to read more
Answer from: Radiation Oncologist at Community Practice
@W. Robert Lee should've been at the table. I prefer the 6 categories as well since it fits better into our clinical decision making alforithm. Never understood how they forgot about the importance of PSA and T3/4 disease
Best of luck trying to simplify all of this for your patients in time to...